Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis.
Gressenberger P, Jud P, Kovacs G, Kreuzer S, Brezinsek HP, Guetl K, Muster V, Kolesnik E, Schmidt A, Odler B, Adelsmayr G, Neumeister P, Brcic L, Zenz S, Weber K, Gary T, Brodmann M, Graninger WB, Moazedi-Fürst FC.
Gressenberger P, et al. Among authors: moazedi furst fc.
J Pers Med. 2021 Jun 25;11(7):600. doi: 10.3390/jpm11070600.
J Pers Med. 2021.
PMID: 34201939
Free PMC article.